Wuhan Hvsen Biotechnology Co.,Ltd. (SHE:300871)
China · Delayed Price · Currency is CNY 22.85
-0.56 (-2.39%)
Sep 2, 2026, 3:04 PM CST
Wuhan Hvsen Biotechnology Market Cap
Wuhan Hvsen Biotechnology has a market cap or net worth of 4.69 billion as of September 1, 2026. Its market cap has increased by 1.41% in one year.
Market Cap
4.69B
Enterprise Value
4.59B
Revenue
1.72B
Ranking
n/a
PE Ratio
14.30
Stock Price
22.85
ChartMarket Cap Chart
Since August 24, 2020, Wuhan Hvsen Biotechnology's market cap has decreased from 6.83B to 4.69B, a decrease of -31.36%. That is a compound annual growth rate of -6.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 4.69B | 12.28% |
| Dec 31, 2025 | 4.18B | 151.73% |
| Dec 31, 2024 | 1.66B | -29.78% |
| Dec 29, 2023 | 2.36B | -29.56% |
| Dec 30, 2022 | 3.36B | -29.11% |
| Dec 31, 2021 | 4.73B | 7.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Aug 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| R&G PharmaStudies | 5.15B |
| Shenzhen Weiguang Biological Products | 5.09B |
| Boji Medical Technology | 4.97B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.82B |
| Beijing Konruns Pharmaceutical | 4.80B |
| Novoprotein Scientific | 4.79B |
| Zhejiang Wecome Pharmaceutical Company | 4.63B |
| ChemPartner PharmaTech | 4.59B |